XANODYNE PHARMACEUTICALS INC — Form D/A
XANODYNE PHARMACEUTICALS INC of NEWPORT, KY, a company, filed a Form D amendment with the SEC on 2009-10-30. The offering totals $87.8M, of which $87.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-10-30
- Form: D/A
- Accession: 0001335480-09-000004
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $87.8M
- Amount sold: $87.8M
- Investors: 35
- Date of first sale: 2009-05-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-79890
Issuer
- Name: XANODYNE PHARMACEUTICALS INC
- CIK: 0001335480
- Entity type: Corporation
- Jurisdiction: DE
- Address: ONE RIVERFRONT PLACE, NEWPORT, KY, 41071
- Phone: 8593716383
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Rolf A Classon | Director | Somerset, NJ |
| Patrick M Enright | Director | Newport, KY |
| Vaughn M Kailian | Director | Boston, MA |
| Dennis Purcell | Director | New York, NY |
| James A Shannon | Director | Newport, KY |
| Steven St. Peter | Director | Kansas City, KS |
| Craig A Tooman | Director | Newport, KY |
| MICHAEL M VALENTINO | Director | DUBLIN, CA |
| Kevin T Anderson | Executive Officer | Newport, KY |
| Daniel W Docherty | Executive Officer | Newport, KY |
| Natasha W Giordano | Executive Officer | Newport, KY |
| Thomas P Jennings | Executive Officer | Newport, KY |
| Rita M O'Connor | Executive Officer | Succasunna, NJ |
| Gary A Shangold | Executive Officer | Newport, KY |
| MICHAEL M VALENTINO | Executive Officer | DUBLIN, CA |
| Peter W Wentworth | Executive Officer | Newport, KY |
| James Shannon | Director | New York, NY |
| Michael Valentino | Director | Bradenton, FL |
| Craig Tooman | Director | London, X0 |
| Stephen A Stamp | Executive Officer | Mason, OH |
| Timothy Arendt | Executive Officer | Newport, KY |
| Stephen St. Peter | Director | Newport, KY |
| Vaughan M Kailian | Director | Newport, KY |
Other filings by this issuer (2)
More